头颈部恶性肿瘤三次及以上放疗的疗效与安全性
PURPOSE: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described.…
要点
- 头颈部≥3程放疗可行但毒性显著,≥3级毒性达45%、≥4级达21%。
- 末次再程放疗后中位局部无复发生存9.1个月,中位总生存10个月。
- 需多学科团队管理,并权衡局部控制与新兴全身治疗机会。
核心结论
- 头颈部重复再程放疗可行,但伴随显著风险,适合多学科团队管理并权衡局部控制与全身治疗机会。
研究设计与样本
- 单中心数据库回顾性查询,回顾治疗计划并选择头颈部区域接受≥3程放疗的患者。
主要发现
- 末次再程放疗后中位局部无复发生存为9.1个月,中位总生存为10个月。
- 15例(45%)报告≥3级毒性,7例(21%)报告≥4级毒性,无5级毒性。
- 20例(61%)在完成重复再程放疗后接受后续治疗。
关键数值与推荐
- ≥3级毒性见于15例(45%),≥4级毒性见于7例(21%),无5级毒性。
- 末次再程放疗后中位局部无复发生存9.1个月,中位总生存10个月。
临床怎么用
- 对头颈部多程放疗患者应由多学科团队评估与管理,并权衡局部控制与全身治疗机会。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: Recurrent head and neck cancers are associated with significant morbidity and mortality. Outcomes of multiple courses of radiation have not yet been described. METHODS AND MATERIALS: A single institution database was queried to retrospectively review treatment plans and select patients who underwent ≥ 3 courses of radiation to the head and neck region. RESULTS: Thirty-three patients were found to have ≥ 3 courses of radiation with overlapping fields. Median local recurrence free survival after last course of reirradiation was 9.1 months and median overall survival was 10 months. Grade 3 and above toxicities were reported in 15 patients (45%). Grade 4 and above toxicities were reported in seven patients (21%). There was no grade 5 toxicity. 20 patients (61%) underwent subsequent therapies following completion of repeat reirradiation. CONCLUSIONS: Repeat reirradiation to the head and neck region is feasible and carries significant risks that are most appropriately managed with a multi-disciplinary team and must be balanced against the potential for local control and opportunities for emerging systemic therapies.
引用
- Xu AJ, Luo L, Leeman JE, et al. Beyond reirradiation: Efficacy and safety of three or more courses of radiation for head and neck malignancies. Clin Transl Radiat Oncol. 2020. PMID: 32382663. doi:10.1016/j.ctro.2020.04.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。